Oracle vs. Palantir: Wall Street Is Neutral on One of These AI Stocks but Expects the Other to Surge
Oracle and Palantir took center stage this year as the artificial intelligence sector continued to dominate the conversation.
Oracle’s cloud and AI pivot drives revenue growth and a strong backlog, but high capex and debt pose risks. Read why I rate ...
Oracle Health, the nation’s second-largest EHR vendor by market share, had a busy December, with health system project and AI customer expansions. Here are 11 times Becker’s reported on the company in ...
Oracle's 2052 bonds are offering a rare 7% yield. Read about the risks and if they're right for income-focused investors.
Hospitals and health systems are entering a period of rapid acceleration in AI. Clinical leaders are reporting tangible gains, from automated note-taking to clearer visibility into patient histories, ...
Oracle cards have become a popular tool for those seeking spiritual guidance, personal insight, and self-discovery in modern divination. With uniquely illustrated decks, they provide profound messages ...
Did people complain – and by people, we mean Wall Street – as the world’s largest bookseller invested huge amounts of money to transform itself into an alternative to driving to Wal-Mart? Or, better ...
Nearly a third of US teenagers say they use AI chatbots daily, a new study finds, shedding light on how young people are embracing a technology that’s raised critical safety concerns around mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results